Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Harnessing function of EMT in cancer drug resistance: a metastasis regulator determines chemotherapy response
Nasim Ebrahimi, Mahdokht Sadat Manavi, Ferdos Faghihkhorasani, et al.
Cancer and Metastasis Reviews (2024) Vol. 43, Iss. 1, pp. 457-479
Closed Access | Times Cited: 20

Showing 20 citing articles:

Comparative Analysis of Acquired Resistance to Bortezomib in Prostate Cancer Cells Using Proteomic and Bioinformatic Tools
Semih Şeker, Betül Şahin, Azmi Yerlikaya
Journal of Cellular and Molecular Medicine (2025) Vol. 29, Iss. 1
Open Access
Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition
Antonino Glaviano, Hannah Lau, Lukas M. Carter, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access
Triple-Negative Breast Cancer Progression and Drug Resistance in the Context of Epithelial–Mesenchymal Transition
Ewa Błaszczak, Paulina Miziak, Adrian Odrzywolski, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 228-228
Open Access
Manzamine A: A Promising Marine-Derived Cancer Therapeutic for Multi-targeted Interactions with E2F8, SIX1, AR, GSK-3β, and V-ATPase - A Systematic Review
Mohammad Amir Mishan, Yeun‐Mun Choo, Jeffery Winkler, et al.
European Journal of Pharmacology (2025), pp. 177295-177295
Closed Access
lncRNAs: New players of cancer drug resistance via targeting ABC transporters
Mohammad Ebrahimnezhad, Sanaz Hassanzadeh Asl, Maede Rezaie, et al.
IUBMB Life (2024) Vol. 76, Iss. 11, pp. 883-921
Closed Access | Times Cited: 5
Long-term di-(2-ethylhexyl) phthalate exposure reduces sorafenib treatment efficacy by enhancing mesenchymal transition in hepatocellular carcinoma
Ming-Syuan Shih, Fat‐Moon Suk, Wan‐Chun Chiu, et al.
Ecotoxicology and Environmental Safety (2024) Vol. 273, pp. 116161-116161
Open Access | Times Cited: 4
Autophagy flux in bladder cancer: Cell death crosstalk, drug and nanotherapeutics
Kuan Liu, Huijing Chen, Yanhong Li, et al.
Cancer Letters (2024) Vol. 591, pp. 216867-216867
Closed Access | Times Cited: 4
Noncoding RNAs and programmed cell death in hepatocellular carcinoma: Significant role of epigenetic modifications in prognosis, chemoresistance, and tumor recurrence rate
Reza Arefnezhad, Sara Ashna, Fatemeh Rezaei‐Tazangi, et al.
Cell Biology International (2024) Vol. 48, Iss. 5, pp. 556-576
Open Access | Times Cited: 3
MARCH2, a Novel Oncogene-regulated SNAIL E3 Ligase, Suppresses Triple-negative Breast Cancer Metastases
Koichi Ito, Ibuki Harada, Criseyda Martinez, et al.
Cancer Research Communications (2024) Vol. 4, Iss. 3, pp. 946-957
Open Access | Times Cited: 2
A novel high‐risk model identified by epithelial–mesenchymal transition predicts prognosis and radioresistance in rectal cancer
Feiyu Qin, Zehua Bian, Lingzhen Jiang, et al.
Molecular Carcinogenesis (2024) Vol. 63, Iss. 11, pp. 2119-2132
Closed Access | Times Cited: 2
Synthesis, characterization and biological research of novel 2-(quinoline-4-carbonyl)hydrazide-acrylamide hybrids as potential anticancer agents on MCF-7 breast carcinoma cells by targeting EGFR-TK
Hany M. Abd El‐Lateef, Duaa Bafail, Noura Hamdi Yousef Alhalees, et al.
RSC Advances (2024) Vol. 14, Iss. 32, pp. 23495-23504
Open Access | Times Cited: 2
Bacteroidetes promotes esophageal squamous carcinoma invasion and metastasis through LPS-mediated TLR4/Myd88/NF-κB pathway and inflammatory changes
Zhongbing Wu, Jianxin Guo, Zhenhuan Zhang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Epithelial–mesenchymal plasticity in cancer: signaling pathways and therapeutic targets
Xiangpeng Wang, Xiaoxia Xue, Mingshi Pang, et al.
MedComm (2024) Vol. 5, Iss. 8
Open Access | Times Cited: 1
Nanomolecular machines: Pioneering precision medicine for neoplastic diseases through advanced diagnosis and treatment
Ruming Li, Jialu Qian, Xiao Zhu, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024) Vol. 1870, Iss. 8, pp. 167486-167486
Closed Access | Times Cited: 1
Role of tight junction proteins in shaping the immune milieu of malignancies
Laxmi Kumari, Reena Yadav, Yashwant Kumar, et al.
Expert Review of Clinical Immunology (2024) Vol. 20, Iss. 11, pp. 1305-1321
Closed Access
Umbilical cord mesenchymal stem cells: a powerful fighter against colon cancer?
Leila Kalantari, Ashkan Hajjafari, Pouya Goleij, et al.
Tissue and Cell (2024) Vol. 90, pp. 102523-102523
Closed Access
Bioengineering nanomaterials for tumor therapy and anti-metastasis
Junjie Cheng, Yuanbo Pan, Jianhua Zou, et al.
Progress in Materials Science (2024), pp. 101375-101375
Closed Access
Spatial analyses revealed S100P + TFF1 + tumor cells in spread through air spaces samples correlated with undesirable therapy response in non-small cell lung cancer
Guangyu Fan, Tongji Xie, Mengwei Yang, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access
FTO/m6A mediates miR-138-5p maturation and regulates gefitinib resistance of lung adenocarcinoma cells by miR-138-5p/LCN2 axis
Dongxiao Ding, Wenjun Shang, Ke Shi, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access
Loss of PERIOD2 (PER2) induces HO-1-mediated epithelial-mesenchymal transition and cisplatin resistance in Epi-A ovarian cancer
Wendy W. Hwang‐Verslues, Grace Y.T. Tan, Priyanka Vinothkumar, et al.
(2024)
Closed Access
Page 1

Scroll to top